LN-005

N/A

Report date: 2025/03/03 10:41:10
NME

Base Information

Drug NameLN-005
Drug Alias NameLN005LN-005
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action78 kDa glucose-regulated protein stimulants
Targets78 kDa glucose-regulated protein
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Huiyong Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai Huiyong Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A